Silgan (NYSE:SLGN) Announces Earnings Results, Beats Expectations By $0.06 EPS

Key Points

• Silgan beat earnings expectations: Third-quarter adjusted EPS rose 7% year over year to $1.31, exceeding the $1.25 consensus, while revenue increased 1.5% to $2.04 billion but fell below the $2.10 billion estimate.
• Outlook improved: Management raised its full-year 2026 adjusted EPS forecast to $3.83–$3.93 and reaffirmed approximately $450 million in free cash flow, citing strong operating performance and growth in fragrance, pharmaceutical dispensing and select food categories.
• Headwinds remain: Weak consumer demand continues to pressure food, beverage, home-care and lawn-and-garden volumes, while the proposed Trivium acquisition is still expected to close in mid-2027 and will require additional investment and integration costs.

Silgan (NYSE:SLGN - Get Free Report) posted its quarterly earnings data on Thursday. The industrial products company reported $1.31 earnings per share for the quarter, beating analysts' consensus estimates of $1.25 by $0.06, Zacks reports. The business had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.10 billion. Silgan had a return on equity of 16.74% and a net margin of 4.05%. Silgan's quarterly revenue was up 1.5% on a year-over-year basis. During the same period in the prior year, the business posted $1.22 earnings per share.

Here are the key takeaways from Silgan's conference call:

• Record third-quarter results: Adjusted EPS rose 7% to $1.31, at the high end of guidance, while adjusted EBIT increased 6% to $235 million. Favorable operating performance, lower interest expense and corporate cost reductions helped offset a higher tax rate.
• Silgan raised its full-year 2026 adjusted EPS outlook to $3.83–$3.93, up 4% at the midpoint from 2025, and reaffirmed approximately $450 million of free cash flow. Fourth-quarter adjusted EPS is expected to be $0.76–$0.86, above the prior-year period.
• Growth initiatives remain strong, including mid-single-digit growth in fragrance products, double-digit North American growth in prescription pharma dispensing, and higher wet pet food and fruit-and-vegetable volumes. Management expects fragrance growth to continue in 2027, supported by new product launches and market-share gains.
• Consumer demand remains pressured in food and beverage, home care and lawn-and-garden markets, with soup volumes particularly weak after customers raised prices to recover inflation. Full-year 2026 volumes are now expected to be comparable with 2025 across all three segments, while Brazil is not expected to meaningfully recover until 2027.
• The proposed Trivium acquisition is still expected to close in mid-2027 and will create Silgan MCC and Silgan DS. Management expects organic earnings and free-cash-flow growth in 2027, but plans incremental capital investment and has not yet quantified the separation and integration costs.

Silgan Trading Up 4.1%

Silgan stock traded up $1.54 during trading hours on Thursday, reaching $39.47. 1,337,322 shares of the company's stock were exchanged, compared to its average volume of 1,053,003. The firm's 50 day simple moving average is $38.40 and its 200 day simple moving average is $41.41. Silgan has a twelve month low of $33.70 and a twelve month high of $49.55. The company has a quick ratio of 0.80, a current ratio of 1.27 and a debt-to-equity ratio of 1.54. The firm has a market capitalization of $4.17 billion, a PE ratio of 15.48, a PEG ratio of 2.29 and a beta of 0.67.

Silgan Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st were issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date was Tuesday, September 1st. Silgan's dividend payout ratio (DPR) is presently 32.94%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. Truist Financial set a $45.00 price target on Silgan and gave the company a "buy" rating in a research report on Monday, October 12th. Citigroup lowered their price objective on Silgan from $54.00 to $49.00 and set a "buy" rating for the company in a research report on Friday, October 2nd. UBS Group set a $38.00 price objective on Silgan and gave the stock a "neutral" rating in a research note on Monday, October 5th. Bank of America upped their target price on Silgan from $53.00 to $58.00 and gave the company a "buy" rating in a report on Tuesday, July 14th. Finally, BMO Capital Markets assumed coverage on shares of Silgan in a research report on Thursday, July 16th. They set an "outperform" rating and a $57.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $50.40.

Silgan News Summary

Here are the key news stories impacting Silgan this week:

• Positive Sentiment: Silgan reported third-quarter EPS of $1.31, above analyst estimates of approximately $1.25-$1.26 and up from $1.22 in the year-earlier period. Silgan Holdings Tops Q3 Earnings Estimates
• Positive Sentiment: Management raised the midpoint of its full-year earnings estimate, signaling improved confidence in expected profitability and supporting the stock’s favorable reaction. Silgan Announces Third Quarter 2026 Results
• Positive Sentiment: Quarterly revenue increased 1.5% year over year to approximately $2.04 billion, indicating modest underlying growth despite the sales miss. Silgan Reports Third-Quarter Results
• Neutral Sentiment: The earnings call and financial updates provide additional detail on third-quarter operating performance and the revised full-year outlook, which investors will assess for evidence that earnings momentum can continue. Silgan Q3 2026 Earnings Call Transcript
• Negative Sentiment: Revenue of $2.04 billion fell short of the approximately $2.10 billion consensus estimate, highlighting weaker-than-expected sales performance and limiting the upside from the earnings beat. Silgan Misses Q3 Revenue Estimates

About Silgan

Silgan Holdings Inc NYSE: SLGN is a manufacturer of rigid packaging products used by consumer goods companies. The company produces metal containers, plastic containers and specialty closures for food, beverage, personal care, household, healthcare, industrial and other products.

Silgan's metal packaging business supplies cans and containers for food, pet food, paint, chemicals, aerosols and other applications. Its plastic packaging operations manufacture bottles, tubs and other containers, while its closures business produces metal and plastic caps, lids and dispensing systems for a range of consumer and industrial products.

Founded in 1987, Silgan serves customers primarily across North America and Europe through a network of manufacturing facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.